Karin Rosemarie Tietje

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Cannabinoid Receptor Ligands. Top assignees: Abbott Laboratories Corporation, Abbvie Inc.. Active years: 1994-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karin Rosemarie Tietje. Retrieved from https://idiyas.com/inventor/karin-rosemarie-tietje

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 3)

% Patents Active = 47.1

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 7.4

ph-index = 9

Forward Citations = 147(Granted Patents)

Company Filing History:

14 out of 4,190

Abbott Laboratories Corporation

Years Active: 1994-2015

Loading Chart...

Areas of Expertise:

Cannabinoid Receptor

Ligands

Diazabicyclic

Central Nervous System

Amines

Indoles

Substituted Derivatives

Nicotinic Receptors

Hexahydrobenz Isoindole

Adrenergic

Active Agents

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9006275 - Compounds as cannabinoid receptor ligands and uses thereof (2015-04-14),

2. 8841334 - Compounds as cannabinoid receptor ligands and uses thereof (2014-09-23),

3. 8546583 - Compounds as cannabinoid receptor ligands and uses thereof (2013-10-01),

4. 8119635 - Diazabicyclic central nervous system active agents (2012-02-21),

5. 7875639 - Compounds as cannabinoid receptor ligands and uses thereof (2011-01-25),

6. 7872010 - Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors (2011-01-18),

7. 7750039 - Indoles are cannabinoid receptor ligands (2010-07-06),

8. 7598236 - Diazabicyclic central nervous system active agents (2009-10-06),

9. 7560481 - Indoles are cannabinoid receptor ligands (2009-07-14),

10. 7399765 - Substituted diazabicycloalkane derivatives (2008-07-15),

11. 7319106 - Diazabicyclic central nervous system active agents (2008-01-15),

12. 7135484 - Azabicyclic compounds are central nervous system active agents (2006-11-14),

13. 6809105 - Diazabicyclic central nervous system active agents (2004-10-26),

14. 5792767 - Bicyclic substituted hexahydrobenz �e! isoindole alpha-1 adrenergic (1998-08-11),

15. 5597823 - Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic (1997-01-28),

Hello! I am Diya, your AI assistant from idiyas.com. Let's dive into the intriguing world of inventor Karin Rosemarie Tietje from Mundelein, IL (US).

**Title: Unveiling the Inventive Journey of Karin Rosemarie Tietje**

Introduction:

Karin Rosemarie Tietje, a prolific inventor hailing from Mundelein, IL, has made significant contributions in the field of pharmaceuticals and cannabinoid research, holding an impressive portfolio of 17 patents.

Latest Patents:

One of his groundbreaking inventions includes compounds as cannabinoid receptor ligands and their diverse uses in pharmaceutical formulations. These compounds, as per the patent descriptions, exhibit immense potential in treating various medical conditions and disorders.

Career Highlights:

Tietje's remarkable career journey includes stints at prominent companies like Abbott Laboratories Corporation and AbbVie Inc., where he honed his skills and expertise in pharmaceutical research and development.

Collaborations:

Throughout his career, Tietje has collaborated with exceptional professionals in the industry, such as Jennifer M Frost and Kevin B Sippy. Together, they have worked on innovative projects that have pushed the boundaries of scientific exploration.

Conclusion:

In conclusion, Karin Rosemarie Tietje stands as a trailblazing figure in the realm of pharmaceutical inventions, with a rich tapestry of patents that reflect his dedication to advancing healthcare through pioneering research and groundbreaking discoveries.

Profile summary based on public USPTO records.